Rhelion Life Sciences Corp. TRUFF
0.02 USD 0.00 (+6.67%)
At closeNov 6, 2026, 4:00 PM EST
0.014 Day range 0.0146
0.011 52-week range 0.033
- YTD
- 0.00%
- 1 year
- -33.33%
News
newsfilecorp.com Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Ships PEX010 to the University of Southern California for the Expanded Mindfulness Assisted Psychedelic Therapy Trial Filament has shipped PEX010 to the Keck School of Medicine of USC for the first order under the expanded supply agreement for its Mindfulness Assisted Psychedelic Therapy trial. Toronto,…
newsfilecorp.com Rhelion Life Sciences' Wholly Owned Subsidiary Filament Health Completes New Extraction of IBEX011, Its Naturally Derived Ibogaine Drug Candidate, and Commences Stability Testing Filament has completed a new extraction of IBEX011 The Company expects Filament to begin stability testing on the new extract shortly Toronto, Ontario--(Newsfile Corp. - November 2, 2026) - Rhelion…